Efficacy of nivolumab and ipilimumab in patients with hepatocellular carcinoma with prior immune-checkpoint inhibitor treatment.

被引:0
|
作者
Cheon, Jaekyung
Kang, Beodeul
Jung, Sang-Hoon
Kim, Chan
Chon, Hongjae
机构
[1] CHA Univ, Sch Med, CHA Bundang Med Ctr, Med Oncol,Dept Internal Med, Seongnam, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Med Oncol, Seongnam, South Korea
[3] CHA Bundang Med Ctr, Seongnam Si, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
554
引用
收藏
页码:554 / 554
页数:1
相关论文
共 50 条
  • [1] Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
    Wong, Jeffrey Sum Lung
    Kwok, Gerry Gin Wai
    Tang, Vikki
    Li, Bryan Cho Wing
    Leung, Roland
    Chiu, Joanne
    Ma, Ka Wing
    She, Wong Hoi
    Tsang, Josephine
    Lo, Chung Mau
    Cheung, Tan To
    Yau, Thomas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [2] Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
    Ji, Jun Ho
    Ha, Sang Yun
    Lee, Danbi
    Sankar, Kamya
    Koltsova, Ekaterina K.
    Abou-Alfa, Ghassan K.
    Yang, Ju Dong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [3] Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
    Wong, Jeffrey Sum Lung
    Kwok, Gin Wai
    Tang, Vikki
    Li, Bryan
    Leung, Roland Ching-Yu
    Chiu, Joanne Wing Yan
    Ma, Ka Wing
    She, Wong-Hoi
    Tsang, Wing Yan Josephine
    Cheung, Tan To
    Yau, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [4] Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
    Daniel Roessler
    Osman Öcal
    Alexander B. Philipp
    Daniel Markwardt
    Stefan Munker
    Julia Mayerle
    Leonie S. Jochheim
    Katharina Hammer
    Christian M. Lange
    Andreas Geier
    Max Seidensticker
    Florian P. Reiter
    Enrico N. De Toni
    Najib Ben Khaled
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3065 - 3073
  • [5] Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
    Roessler, Daniel
    Oecal, Osman
    Philipp, Alexander B.
    Markwardt, Daniel
    Munker, Stefan
    Mayerle, Julia
    Jochheim, Leonie S.
    Hammer, Katharina
    Lange, Christian M.
    Geier, Andreas
    Seidensticker, Max
    Reiter, Florian P.
    De Toni, Enrico N.
    Ben Khaled, Najib
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3065 - 3073
  • [6] Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
    Gul, Anita
    Stewart, Tyler F.
    Mantia, Charlene M.
    Shah, Neil J.
    Gatof, Emily Stern
    Long, Ying
    Allman, Kimberly D.
    Ornstein, Moshe C.
    Hammers, Hans J.
    McDermott, David F.
    Atkins, Michael B.
    Hurwitz, Michael
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3088 - +
  • [7] EFFICACY AND SAFETY OF IMMUNE CHECKPOINT INHIBITOR RECHALLENGE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Scheiner, Bernhard
    Pomej, Katharina
    Pressiani, Tiziana
    Cammarota, Antonella
    Fruendt, Thorben W.
    Von Felden, Johann
    Schulze, Kornelius
    Roessler, Daniel
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Deibel, Ansgar
    Siebenhuner, Alexander
    Shmanko, Kateryna
    Radu, Pompilia
    Schwacha, Birgit
    Ebert, Matthias P.
    Teufel, Andreas
    Djanani, Angela
    Hucke, Florian
    Balcar, Lorenz
    Venerito, Marino
    Sinner, Friedrich
    Trauner, Michael H.
    D'Alessio, Antonio
    Pinato, David James
    Peck-Radosavljevic, Markus
    Dufour, Jean-Francois
    Weinmann, Arndt
    Kremer, Andreas E.
    De Toni, Enrico
    Rimassa, Lorenza
    Pinter, Matthias
    [J]. HEPATOLOGY, 2022, 76 : S1367 - S1369
  • [8] Drug Induced Organizing Pneumonia By Immune-Checkpoint Inhibitor, Nivolumab
    Nagamata, M.
    Yomota, M.
    Okamura, T.
    Yoshino, K.
    Hishima, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Ipilimumab/Nivolumab for Immune Checkpoint Inhibitor-induced Encephalitis
    Janssen, Sarah
    Lindhof, Harm-Henning
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 166 - 166
  • [10] The effect of antibiotic use on immune-checkpoint inhibitor efficacy in patients with advanced urothelial carcinoma.
    Khan, Mohammad
    Radakovich, Nathan
    Rini, Brian, I
    Mian, Omar Y.
    Ornstein, Moshe Chaim
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)